drug
(meloxicam + rizatriptan benzoate)
Marketedupdated 3mo agoby $AXSM Axsome Therapeutics, Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 30, 2028
~1.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (82)
- Mar 10, 2045method-of-use (U-1719)US 12544383
- Dec 29, 2041method-of-use (U-1719)US 12370196
- May 28, 2040method-of-use (U-1719)US 12128052
- May 28, 2040method-of-use (U-1719)US 12551488
- May 28, 2040method-of-use (U-1719)US 12551489
- May 18, 2038method-of-use (U-4356)US 12472256
- May 18, 2038method-of-use (U-4134)US 12472257
- May 18, 2038formulationUS 12472258
- Apr 11, 2036method-of-use (U-4133)US 10029010
- Apr 11, 2036formulationUS 10058614
- Apr 11, 2036formulationUS 10137131
- Apr 11, 2036method-of-use (U-1719)US 10195278
- Apr 11, 2036method-of-use (U-1719)US 10265324
- Apr 11, 2036method-of-use (U-1719)US 10363312
- Apr 11, 2036method-of-use (U-4134)US 10369224
- Apr 11, 2036method-of-use (U-4135)US 10426839
- Apr 11, 2036formulationUS 10463736
- Apr 11, 2036method-of-use (U-1719)US 10471014
- Apr 11, 2036method-of-use (U-1719)US 10471069
- Apr 11, 2036method-of-use (U-1719)US 10512692
- Apr 11, 2036method-of-use (U-1719)US 10512693
- Apr 11, 2036method-of-use (U-1719)US 10517950
- Apr 11, 2036method-of-use (U-1719)US 10532101
- Apr 11, 2036method-of-use (U-1719)US 10537642
- Apr 11, 2036method-of-use (U-1719)US 10561664
- Apr 11, 2036method-of-use (U-1719)US 10583144
- Apr 11, 2036method-of-use (U-1719)US 10653777
- Apr 11, 2036method-of-use (U-1719)US 10688102
- Apr 11, 2036method-of-use (U-1719)US 10688185
- Apr 11, 2036method-of-use (U-1719)US 10695429
- Apr 11, 2036method-of-use (U-1719)US 10695430
- Apr 11, 2036method-of-use (U-4136)US 10702535
- Apr 11, 2036method-of-use (U-1719)US 10702602
- Apr 11, 2036method-of-use (U-1719)US 10722583
- Apr 11, 2036method-of-use (U-1719)US 10729696
- Apr 11, 2036method-of-use (U-1719)US 10729697
- Apr 11, 2036method-of-use (U-1719)US 10729773
- Apr 11, 2036method-of-use (U-1719)US 10758617
- Apr 11, 2036method-of-use (U-1719)US 10758618
- Apr 11, 2036method-of-use (U-1719)US 10780165
- Apr 11, 2036method-of-use (U-1719)US 10780166
- Apr 11, 2036method-of-use (U-1719)US 10799588
- Apr 11, 2036method-of-use (U-1719)US 10821181
- Apr 11, 2036method-of-use (U-1719)US 10821182
- Apr 11, 2036method-of-use (U-1719)US 10894053
- Apr 11, 2036method-of-use (U-1719)US 10905693
- Apr 11, 2036method-of-use (U-1719)US 10918722
- Apr 11, 2036method-of-use (U-1719)US 10933136
- Apr 11, 2036method-of-use (U-1719)US 10933137
- Apr 11, 2036method-of-use (U-1719)US 10940153
- Apr 11, 2036method-of-use (U-1719)US 10987358
- Apr 11, 2036method-of-use (U-1719)US 11013805
- Apr 11, 2036method-of-use (U-1719)US 11013806
- Apr 11, 2036method-of-use (U-1719)US 11020483
- Apr 11, 2036method-of-use (U-1719)US 11045549
- Apr 11, 2036method-of-use (U-1719)US 11135295
- Apr 11, 2036method-of-use (U-1719)US 11207328
- Apr 11, 2036method-of-use (U-1719)US 11219626
- Apr 11, 2036method-of-use (U-1719)US 11285213
- Apr 11, 2036method-of-use (U-1719)US 11331323
- Apr 11, 2036method-of-use (U-1719)US 11369684
- Apr 11, 2036method-of-use (U-1719)US 11426414
- Apr 11, 2036method-of-use (U-1719)US 11471464
- Apr 11, 2036method-of-use (U-1719)US 11471465
- Apr 11, 2036method-of-use (U-1719)US 11504429
- Apr 11, 2036method-of-use (U-1719)US 11510927
- Apr 11, 2036method-of-use (U-1719)US 11571428
- Apr 11, 2036method-of-use (U-1719)US 11602563
- Apr 11, 2036method-of-use (U-1719)US 11607456
- Apr 11, 2036method-of-use (U-1719)US 11617755
- Apr 11, 2036method-of-use (U-1719)US 11617756
- Apr 11, 2036method-of-use (U-1719)US 11617791
- Apr 11, 2036method-of-use (U-1719)US 11628173
- Apr 11, 2036method-of-use (U-1719)US 11712441
- Apr 11, 2036method-of-use (U-1719)US 11738085
- Apr 11, 2036method-of-use (U-1719)US 11759522
- Apr 11, 2036method-of-use (U-1719)US 11801250
- Apr 11, 2036method-of-use (U-1719)US 11806354
- Apr 11, 2036method-of-use (U-1719)US 11826370
- Apr 11, 2036method-of-use (U-1719)US 11865117
- Apr 11, 2036method-of-use (U-4133)US 12485176
- Apr 11, 2036formulationUS 9821075
FDA exclusivities (1)
- Jan 30, 2028NPNP1.4y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 21m ago
Found something off?
comments(0)
5-min edit window · permanent after that